KNSA
Kiniksa Pharmaceuticals International, plcCIK 0001730430
Showing the last 10 days.Sign up free for 90 days
Insider trades
View all KNSA insider trades| Type | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|
| Exercise | Patel Sanj K CHAIRMAN & CEO, Director | 231,237 | $2.4M | Nov 3, 2026 | Nov 4, 2026 | |
| Sell | Patel Sanj K CHAIRMAN & CEO, Director | 402,494 | $37.4M | Nov 3, 2026 | Nov 4, 2026 | |
| Exercise | Ragosa Mark CHIEF FINANCIAL OFFICER | 36,783 | $480K | Nov 2, 2026 | Nov 3, 2026 | |
| Sell | Ragosa Mark CHIEF FINANCIAL OFFICER | 36,783 | $3.4M | Nov 2, 2026 | Nov 3, 2026 | |
| Exercise | Paolini John F. CHIEF MEDICAL OFFICER | 96,000 | $2.3M | Nov 2, 2026 | Nov 3, 2026 | |
| Sell | Paolini John F. CHIEF MEDICAL OFFICER | 96,000 | $8.9M | Nov 2, 2026 | Nov 3, 2026 |
Earnings
PaidCompany revenue, EPS, net income, and guidance the moment they file, parsed from SEC 8-K earnings releases. Create a free account to get started, then unlock earnings on a paid plan.
- Revenue and adjusted / GAAP EPS per quarter
- GAAP net income with profit and loss at a glance
- Forward EPS guidance when companies provide it